Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Total Voting Rights

3 June 2024 15:00 BST Transparency DirectiveVoting rights and capital The following notification is made in accordance with the UK Financial Conduct Authority's Disclosure and Transparency Rule 5.6.1. As at 31 May 2024 the issued share capital of AstraZeneca PLC with voting rights is 1,550,256,302 ordinary shares of US$0.25. No shares are held in Treasury. Therefore, the total number of voting rights in AstraZeneca PLC is 1,550,256,302. The above figure for the total number of voting rights may be used by shareholders as the denominator for the calculations by which they will

Conversion of Scandic’s convertible bonds in an aggregated nominal amount of SEK 6 million to shares

In 2021 Scandic Hotels Group AB (publ) (“Scandic”) issued convertible bonds in an aggregated nominal amount of SEK 1,800 million. Convertible bonds in an aggregated nominal amount of SEK 6 million have been converted to shares. After the conversion, the aggregated nominal amount for the outstanding convertible bonds amounts to SEK 1,169.3 million.Through the conversion, the total number of shares and votes in Scandic increases with 138,369 to in total 192,191,987. Through the conversion, the share capital increases with SEK 34,592.25 to in total SEK 48,047,996.75. For more information,

Getinge Announces U.S. Launch of XEN Cleaning Chemistries to Enhance Safety and Efficiency in Sterile Processing Departments

Today Getinge announced the launch of XEN, a new and improved range of cleaning chemistries designed to optimize equipment performance, extend the lifespan of surgical instruments, and improve safety and efficiency in sterile processing departments (SPDs) across the U.S. The XEN product line features 16 advanced chemical solutions designed to support SPDs in every stage, from pretreatment and manual cleaning to ultrasonic cleaning, automated cleaning, final rinsing, and maintenance. Each formula is crafted to ensure thorough cleaning and decontamination, supporting safe and

Nytida acquires Evus Omsorg

Nytida, a part of Ambea group, acquires Evus Omsorg AB. The acquisition includes three assisted living facilities and two daily activity centers.Evus Omsorg was founded in 2015 and the units are in Södertälje, Nyköping, Nacka, Skogås and Sorunda. The operations include 51 placements and 31 employees. Revenue for 2023 was SEK 40 million. The acquisition was closed on June 3, 2024.  -We welcome care receivers and their loved ones, employees and clients to Nytida. Evus Omsorg complements us well and is in line with our strategy to acquire quality companies, says Fredrik von Malmborg,

Eco Wave Power to Present at the Spring MicroCap Rodeo Conference in New York

New York, June 3, 2024 – Eco Wave Power Global AB (publ) (“Eco Wave Power” or the “Company”) (Nasdaq: WAVE), a leading onshore wave energy technology company that developed a patented, smart and cost-efficient technology for turning ocean and sea waves into green electricity, announced today that it will be participating in the Spring MicroCap Rodeo Conference that will be held on Thursday, June 6[th], 2024, in NYC.Inna Braverman, Founder and CEO, will be attending the conference and discussing: · Eco Wave Power’s operational project results · Eco Wave Power’s upcoming projects in

Agilyx technology produces on-spec product in Japan

Agilyx ASA (OSE: AGLX; OTCQX: AGXXF) (“Agilyx” or “the company”), a technology company that enables customers to recycle the most challenging post-use plastics to high value, virgin-equivalent products, is proud to announce that its depolymerization technology was successfully demonstrated during commissioning of Toyo Styrene’s 10 ton-per-day chemical recycling facility  in Japan.The recycling plant will convert post-use polystyrene into a styrene

Hufvudstaden begins search for new President of NK

Hufvudstaden will be replacing the President of Nordiska Kompaniet (NK). A recruitment process will begin immediately and the current President, Bo Wikare – who is also the Vice President of Hufvudstaden and a member of Group Management – will leave the company at the end of August, 2024.   NK is undergoing a comprehensive process of development and change to address the transformation taking place in the retail sector. To take NK further on its journey of change, the Board and the President of Hufvudstaden see a need for a leader with broader expertise in the field of retail. A

Inside information: YIT commences written procedure to solicit consents to amend the terms and conditions of its senior unsecured green fixed rate notes due 2026

YIT Corporation Inside information 3 June 2024 at 3:27 p.m.NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, TO ANY PERSON LOCATED OR RESIDENT IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE, SOUTH AFRICA, THE UNITED STATES OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURES. Inside information: YIT commences written procedure to solicit consents to amend the terms and conditions of its senior unsecured green fixed rate notes due 2026 YIT Corporation (“YIT”)

Inside information: YIT considers the issuance of secured green notes and commencement of a consent solicitation procedure to amend the terms and conditions of its green notes due 2026

YIT Corporation Inside information 3 June 2024 at 3:25 p.m.NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE, SOUTH AFRICA OR SUCH OTHER COUNTRIES OR OTHERWISE IN SUCH CIRCUMSTANCES IN WHICH THE OFFERING OF THE NEW NOTES OR THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. Inside information: YIT considers the issuance of secured green notes and commencement of a consent solicitation procedure to amend the terms and conditions of its green notes due

David Högnelid appointed Vice President Minerals at LKAB

International mining and minerals group, LKAB, are pleased to announce the appointment of David Högnelid as Vice President Minerals, effective immediately.“David joined LKAB in 2012 and has held several senior leadership roles, most recently as Chief Strategy & Business Development Officer for Business Area Special Products. David has been an invaluable member of the senior management team, with his in-depth knowledge of the minerals markets and complex value chains. I’m confident David will deliver our ambition to grow the business and become market leaders in responsible mineral

Relais Group Plc - Managers' transactions - Popov

Relais Group Plc, Stock Exchange Release, 3 June 2024 at 3:00 p.m. EEST ____________________________________________ Person subject to the notification requirement Name: Popov, Jan Position: Other senior manager Issuer: Relais Group Plc LEI: 743700X9S8FVYRI20J88 Notification type: INITIAL NOTIFICATION Reference number: 743700X9S8FVYRI20J88_20240603092858_11 ____________________________________________ Transaction date: 2024-05-31 Venue not applicable Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT INSTRUMENT Instrument name: Option

Relais Group Plc - Managers' transactions - Garcia

Relais Group Plc, Stock Exchange Release, 3 June 2024 at 3:00 p.m. EEST ____________________________________________ Person subject to the notification requirement Name: Garcia, Juan Position: Other senior manager Issuer: Relais Group Plc LEI: 743700X9S8FVYRI20J88 Notification type: INITIAL NOTIFICATION Reference number: 743700X9S8FVYRI20J88_20240603093109_18 ____________________________________________ Transaction date: 2024-05-31 Venue not applicable Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT INSTRUMENT Instrument name: Option

Relais Group Plc - Managers' transactions - Garcia

Relais Group Plc, Stock Exchange Release, 3 June 2024 at 3:00 p.m. EEST ____________________________________________ Person subject to the notification requirement Name: Garcia, Juan Position: Other senior manager Issuer: Relais Group Plc LEI: 743700X9S8FVYRI20J88 Notification type: INITIAL NOTIFICATION Reference number: 743700X9S8FVYRI20J88_20240603092931_12 ____________________________________________ Transaction date: 2024-05-31 Venue not applicable Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT INSTRUMENT Instrument name: Option

Lundbeck presents innovative first in human trial design of Lu AG13909 for potential treatment of congenital adrenal hyperplasia

Lundbeck is to showcase innovative trial design at ENDO 2024 of the first in human trial of Lu AG13909 for congenital adrenal hyperplasia (CAH), a rare debilitating disease with excess morbidity and mortality.H. Lundbeck A/S (Lundbeck) will present the novel design of the first in human trial of Lu AG13909, a potential first-in-class treatment for CAH, at ENDO in Boston. The presentation will take place on 3 June 2024, at 12:00 (noon) EDT. The poster is to be presented by trial investigator Dr. Srirangalingam Umasuthan, University College London Hospitals, London, UK, who said: “We

Relais Group Plc - Managers' transactions - Seppänen

Relais Group Plc, Stock Exchange Release, 3 June 2024 at 3:00 p.m. EEST ____________________________________________ Person subject to the notification requirement Name: Seppänen, Sebastian Position: Other senior manager Issuer: Relais Group Plc LEI: 743700X9S8FVYRI20J88 Notification type: INITIAL NOTIFICATION Reference number: 743700X9S8FVYRI20J88_20240603093003_15 ____________________________________________ Transaction date: 2024-05-31 Venue not applicable Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT INSTRUMENT Instrument name:

Relais Group Plc - Managers' transactions - Popov

Relais Group Plc, Stock Exchange Release, 3 June 2024 at 3:00 p.m. EEST ____________________________________________ Person subject to the notification requirement Name: Popov, Jan Position: Other senior manager Issuer: Relais Group Plc LEI: 743700X9S8FVYRI20J88 Notification type: INITIAL NOTIFICATION Reference number: 743700X9S8FVYRI20J88_20240603093003_16 ____________________________________________ Transaction date: 2024-05-31 Venue not applicable Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT INSTRUMENT Instrument name: Option

Relais Group Plc - Managers' transactions - Mikkonen

Relais Group Plc, Stock Exchange Release, 3 June 2024 at 3:00 p.m. EEST ____________________________________________ Person subject to the notification requirement Name: Mikkonen, Ville Position: Other senior manager Issuer: Relais Group Plc LEI: 743700X9S8FVYRI20J88 Notification type: INITIAL NOTIFICATION Reference number: 743700X9S8FVYRI20J88_20240603093003_17 ____________________________________________ Transaction date: 2024-05-31 Venue not applicable Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT INSTRUMENT Instrument name:

Relais Group Plc - Managers' transactions - Ekström

Relais Group Plc, Stock Exchange Release, 3 June 2024 at 3:00 p.m. EEST ____________________________________________ Person subject to the notification requirement Name: Ekström, Thomas Position: Chief Financial Officer Issuer: Relais Group Plc LEI: 743700X9S8FVYRI20J88 Notification type: INITIAL NOTIFICATION Reference number: 743700X9S8FVYRI20J88_20240603093003_14 ____________________________________________ Transaction date: 2024-05-31 Venue not applicable Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT INSTRUMENT Instrument name:

Relais Group Plc - Managers' transactions - Ekholm

Relais Group Plc, Stock Exchange Release, 3 June 2024 at 3:00 p.m. EEST ____________________________________________ Person subject to the notification requirement Name: Ekholm, Arni Position: Chief Executive Officer Issuer: Relais Group Plc LEI: 743700X9S8FVYRI20J88 Notification type: INITIAL NOTIFICATION Reference number: 743700X9S8FVYRI20J88_20240603093003_13 ____________________________________________ Transaction date: 2024-05-31 Venue not applicable Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT INSTRUMENT Instrument name:

Relais Group Plc - Managers' transactions - Ekholm

Relais Group Plc, Stock Exchange Release, 3 June 2024 at 3:00 p.m. EEST ____________________________________________ Person subject to the notification requirement Name: Ekholm, Arni Position: Chief Executive Officer Issuer: Relais Group Plc LEI: 743700X9S8FVYRI20J88 Notification type: INITIAL NOTIFICATION Reference number: 743700X9S8FVYRI20J88_20240603092858_10 ____________________________________________ Transaction date: 2024-05-31 Venue not applicable Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT INSTRUMENT Instrument name:

Outcome reached in the collective labour agreement negotiations at UPM Raflatac

(UPM, Helsinki, Finland, 3 June 2024 at 15:00 EEST) – UPM Raflatac and the Paper Workers' Union have reached an outcome in the collective labour agreement negotiations concerning UPM Raflatac’s Tampere factory in Finland. "The negotiations were conducted in a very good spirit and constructively from start to finish. I would like to thank the Paper Workers’ Union for its solution-oriented approach and for the good negotiations. The solution will enable the long-term development of the Tampere factory," says Antti Waajakoski, General Manager of UPM Raflatac’s Tampere factory. The new

Getinge introduces Poladus 150 – the future of low-temperature sterilization

Today, Getinge unveils the Poladus 150, its latest innovation in low-temperature sterilization, designed for heat-sensitive surgical instruments. Equipped with advanced cross-contamination barrier technology, Poladus 150 plays a crucial role in preventing healthcare acquired infections (HCAIs). Getinge’s new Vaporized Hydrogen Peroxide (VH2O2) low-temp sterilizer Poladus 150 operates within a gentle temperature of up to 55°C, ensuring that non-lumen, flexible lumen, and rigid lumen instruments are ready for the next surgery. “Today marks a significant milestone for our

There are no items matching the current filter
There are no more items matching the current filter
Back to top